Komori
Vital Ksk Holdings (3151) · InitiativeRestated

Strengthening expertise through therapeutic-area liaisons

First written in FY2016. 9 of 12 entries say "Restated". Latest entry: FY2026.

12entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY2018RestatedFY2019-Q3 – FY2020AdvancedFY2025-H12016: 120162017: 320172018: 320182019: 220192020: 120202021: 020212022: 020222023: 020232024: 120242025: 020252026: 12026
Same theme, other companies
Reform of MS Sales Functions Centered on Medical Management Specialist CertificationA theme 3 companies write about · 0 as a headwind · 5 as a tailwind

0 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2026RestatedAnnual report

    「With the aim of improving our presence in the hospital market, we are developing MAPs (Medical Assist Partners), who are well versed in hospital treatments, pharmaceuticals, equipment and diagnostic reagents, and continuously strengthening their capabilities and functions. These include cancer liaisons with specialized knowledge of cancer drugs, Medical MSs specializing in medical devices, and the Lab Access Department, which is strengthening approaches to pathology laboratories.」

    Regarding the strengthening of expertise by specialty, the Company is reaffirming its structure, including specialist personnel and organizations such as MAPs, cancer liaisons, Medical MSs and the Lab Access Department.
  2. FY2025-H1AdvancedAnnual report

    「We newly established the Women’s Healthcare Solutions Department (WHS Department), a sales organization primarily comprising women, and began operations in July 2024. By conducting sales activities leveraging our expertise for the obstetrics and gynecology departments under its responsibility, we are not only experiencing the strength of the touchpoints created by a specialist organization, but also」

    Regarding the strengthening of expertise by specialty, the Company newly established the WHS Department for diseases and health issues specific to women and began operations in July 2024.
  3. FY2020RestatedAnnual report

    「In addition to the “liaisons by specialty,” there are also “dementia liaisons” and “home care liaisons,” which serve as bridges between regional medical and nursing care services. More recently, we have been developing “regenerative medicine liaisons” with specialized knowledge of the cutting-edge regenerative medicine field.」

    Continuing to strengthen expertise through liaisons by specialty in areas including cancer, dementia, home care and regenerative medicine.
  4. FY2019RestatedAnnual report

    「Within the Group, we will also proceed with the rollout of regenerative medicine liaisons to enhance our expertise in regenerative medicine.」

    Continuing to roll out regenerative medicine liaisons.
  5. FY2019-Q3RestatedAnnual report

    「Within the Group, we will also proceed with the rollout of regenerative medicine liaisons (Note 1) to enhance our expertise in regenerative medicine.」

    Continuing to roll out regenerative medicine liaisons to enhance expertise in regenerative medicine.
  6. FY2019-Q2RaisedAnnual report

    「Within the Group, we will also proceed with the rollout of regenerative medicine liaisons (Note 1) to enhance our expertise in regenerative medicine.」

    The Company has indicated a policy of expanding its liaison rollout to regenerative medicine in addition to the existing areas of home care and cancer treatment, thereby broadening the scope of its specialist fields.
  7. FY2018RestatedAnnual report

    「Establishing liaisons by specialty with enhanced expertise in areas such as home care and cancer treatment.」

    Continuing measures to establish liaisons by specialty in areas such as home care and cancer treatment and strengthen expertise.
  8. FY2018-Q3RestatedAnnual report

    「We have conducted a broad range of business activities in the medical and nursing care fields, including establishing liaisons by specialty to strengthen expertise in areas such as home care and cancer treatment, strengthening the sale and rental of welfare equipment after 32 MSs obtained certification as welfare equipment specialist consultants, and rolling out Meron Support (Note 2), which supports the development of primary care pharmacies and health-support pharmacies.」

    Continuing measures to establish liaisons by specialty in areas such as home care and cancer treatment and strengthen expertise.
  9. FY2018-Q2RestatedAnnual report

    「We have conducted a broad range of business activities in the medical and nursing care fields, including establishing liaisons by specialty to strengthen expertise in areas such as home care and cancer treatment, strengthening the sale and rental of welfare equipment after 32 MSs obtained certification as welfare equipment specialist consultants, and rolling out Meron Support (Note 2), which supports the development of primary care pharmacies and health-support pharmacies.」

    Continuing measures to establish liaisons by specialty in areas such as home care and cancer treatment and strengthen expertise.
  10. FY2018-Q1RestatedAnnual report

    「Establishing liaisons by specialty with enhanced expertise in areas such as home care and cancer treatment.」

    Continuing measures to establish liaisons by specialty in areas such as home care and cancer treatment and strengthen expertise.
  11. FY2017RestatedAnnual report

    「We will establish liaisons by specialty (Note 2), seek to strengthen our expertise, and contribute to regional healthcare.」

    Continuing to strengthen expertise through liaisons by specialty.
  12. FY2016First statedAnnual report

    「We will establish liaisons by specialty (Note 2), seek to strengthen our expertise, and contribute to regional healthcare.」

    A measure to assign MSs with specialized knowledge of diseases and medical fields.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Vital Ksk Holdings yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Strengthening expertise through therapeutic-area liaisons | VITAL KSK HOLDINGS,INC. (3151) | Komori